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Whether being small for gestational age (SGA) increases the risk of adverse neurodevelop-
mental outcome in premature infants remains controversial.
Objective
to study the impact of SGA (birthweight < percentile 10) on cognition, behavior, neurodeve-
lopmental impairment and use of therapy at 5 years old.
Methods
This population-based prospective cohort included infants born before 32 weeks of gesta-
tion. Cognition was evaluated with the K-ABC, and behavior with the Strengths and Difficul-
ties Questionnaire (SDQ). Primary outcomes were cognitive and behavioral scores, as well
as neurodevelopmental impairment (cognitive score < 2SD, hearing loss, blindness, or ce-
rebral palsy). The need of therapy, an indirect indicator of neurodevelopmental impairment,
was a secondary outcome. Linear and logistic regression models were used to analyze the
association of SGA with neurodevelopment.
Results
342/515 (76%) premature infants were assessed. SGA was significantly associated with
hyperactivity scores of the SDQ (coefficient 0.81, p < 0.04), but not with cognitive scores,
neurodevelopmental impairment or the need of therapy. Gestational age, socio-economic
status, and major brain lesions were associated with cognitive outcome in the univariate
and multivariate model, whereas asphyxia, sepsis and bronchopulmonary dysplasia were
associated in the univariate model only. Severe impairment was associated with fetal tobac-
co exposition, asphyxia, gestational age and major brain lesions. Different neonatal factors
were associated with the use of single or multiple therapies: children with one therapy were
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more likely to have suffered birth asphyxia or necrotizing enterocolitis, whereas the need for
several therapies was predicted by major brain lesions.
Discussion
In this large cohort of premature infants, assessed at 5 years old with a complete panel of
tests, SGA was associated with hyperactive behavior, but not with cognition, neurodevelop-
mental impairment or use of therapy. Birthweight <10th percentile alone does not appear to
be an independent risk factor of neurodevelopmental adverse outcome in preterm children.
Introduction
Each year 15 million babies, or 1/10 babies, are born premature, of whom 1 million die and
many suffer from lifelong disabilities[1]. Very preterm children, born before the 32nd week of
gestation, are especially at risk of long-termmorbidities, due to numerous antenatal or neonatal
variables. Among them, infants born with a birthweight below the 10th percentile, or small for
gestational age (SGA), are estimated to encompass 15 to 30% of very preterm infants[2]. These
SGA infants are small either due to constitutional reasons, or have suffered from intrauterine
growth restriction (IUGR), secondary to maternal, placental, fetal or environmental factors[3].
The etiology of SGA is frequently unknown in population studies and depends on antenatal in-
formation about intrauterine growth of the fetus and materno-fetal circulation. Many studies
use the term intrauterine growth restriction (IUGR) indifferently for SGA and IUGR.
SGA and IUGR infants have been shown to be at risk of increased neonatal mortality and
short- and long-term morbidities, in term or preterm born infants [4–7]. Imaging studies have
shown alterations in brain structure and reduced brain volumes in IUGR preterm infants com-
pared to appropriate birth weight controls [8, 9]. However, there are conflicting results as to
long term neurodevelopmental outcome, with some studies showing no difference [10–12],
whereas others reported increased levels of cognitive and behavioral difficulties [13, 14]. There
is yet no clear explanation for this possible altered neurodevelopment.
Our aim was thus, in a cohort of children born before 32 weeks of gestation, to study the rel-
ative impact of SGA, defined as a birthweight below the 10th percentile, on neurodevelopmen-
tal outcome at 5 years old, assessed with a panel of tests examining different aspects of child
neurodevelopment. Our primary outcome was the neurodevelopmental status assessed by cog-
nitive and behavioral scores and neurological examination. Our secondary outcome was an in-
direct evaluation of neurodevelopmental impairment, through the need of therapy.
Methods
Design
This study was nested in a population based longitudinal prospective cohort of premature in-
fants hospitalized in a tertiary care neonatal intensive care unit.
Population
Consisted of all preterm infants admitted to the Clinic of Neonatology of the University Hospital
in Lausanne, Switzerland between 01.01.2000 and 31.12.2005. Patients with severe brain malfor-
mations, lethal malformations, or genetic disorders known to interfere with neurodevelopment
were excluded. As is the case in all tertiary care centers taking part in the Swiss Neonatal and
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Follow-up group, specialized neurodevelopmental follow-up was offered to all families when the
infants left the Clinic, and the families were informed of the aims of this follow-up, which was to
offer early detection and treatment of developmental issues.
Ethical statement
According to the Swiss law during the study period, no written informed consent was neces-
sary for retrospective observational studies. The local Human Research Ethics Committee
(Commission cantonale d’éthique de la recherche sur l’être humain) and the hospital direction
granted a general approval for research on coded or anonymized retrospective data. Families
were orally informed of the possibility of research using the data, and children were included
in the database if the parents did not refuse it. Data were collected in a specific database accessi-
ble only to clinicians involved in the care of the patients. To analyze the dataset, an extraction
was made, the result of which was coded data.
Data collection
All perinatal and follow-up data were collected in a specific database: Perinatal data known
from the literature to be associated with developmental outcome of premature infants were re-
trieved from the child’s file and entered in the database at the moment of the first follow-up
visit. Prenatal data were self-reported mother’s smoking during pregnancy, gender, multiple
pregnancy and parental socioeconomic status according to Largo[15], which entails a 6 point
scale for each parent, with recorded mother’s education (1 = university and 6 = special or no
schooling) and father’s occupation (1 = leading position and 6 = unskilled labor). The scores are
thus distributed from 2–12, and were categorized as high (2–5), middle (6–8) and low (9–12)
socioeconomic status.
The postnatal data collected were: gestational age in completed weeks of gestation, assessed
with best obstetric estimate comprised of the mother’s last menstrual period when available,
and with early first trimester ultrasound scan, birthweight, and birthweight percentile. SGA
was defined as being<10th percentile for the weight based on the growth curves by Voigt
et al[16]. Birth asphyxia according to Apgar score (Apgar less than 6 at 5 minutes) and to um-
bilical cord blood pH (arterial cord blood pH less than 7.0), presence of proven sepsis defined
as clinical signs and at least one positive blood culture at any point during the hospital stay,
proven necrotizing enterocolitis (NEC), bronchopulmonary dysplasia defined as a need for
supplemental oxygen or ventilatory support at 36 weeks postmenstrual age (BPD), major
brain lesions (intraventricular hemorrhage grade III or more, cystic periventricular leucoma-
lacia according to Papile)[17]
Follow-up data were entered in the database at the subsequent visits, at the ages of 6 and 18
months (age since term), and at 3.5 and 5 years old, the data about the latter examination were
used for this study; they included cognitive and behavioral score, as well as neurological assess-
ment and record of the use of therapy, as described below.
Primary outcomes
Cognitive outcome at 5 years old. Cognitive development was assessed with the French
version of Kaufman Assessment Battery for Children (K-ABC)[18], which entails 3 subscales
of sequential processes, simultaneous processes, and composite mental processes (CMP),
judged to be an equivalent of an intelligence quotient. This last score has an expected mean of
100 and a standard deviation of 15. For children known to have major developmental prob-
lems, the psychologist may have chosen to use another standardized test, such as Wechsler In-
telligence for preschool and primary school, third edition (WPPSI-III)[19], also with a mean at
Neurodevelopment of Small for Gestational Age Preterm Infants
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100 and a standard deviation of 15, or rarely McCarthy Scales of Children’s Abilities[20, 21] of
which the mean is 100 and the standard deviation 16. Because of the different standard devia-
tions, the results of the 3 tests were converted to z-scores, which were used for the analysis, as
has been previously done and published [22].
Behavioral outcome. Caregivers filled in the French version of the “Strengths and Diffi-
culties Questionnaire”(SDQ), a validated tool to assess different aspects of behavior[23]. This
questionnaire consists of 25 questions, and the results entail five subscales of emotional, behav-
ior, hyperactivity, relational, and prosocial issues, and a total problem score [24].
Neurological outcome. Children were subjected to a detailed neurological examination to
assess neuromotor function and exclude cerebral palsy, vision and hearing were tested. Cere-
bral palsy was defined as a disorder of movement and/or posture and of motor function, due to
a non-progressive interference, lesion, or abnormality of the developing/immature brain [25].
Neurodevelopmental impairment consisted in a composite endpoint of IQ z-score< -2 (by
definition mental retardation), or cerebral palsy any grade [26], or severe hearing (corrected or
not by hearing aids) or vision problems (blindness in at least one eye), and normal outcome
consisted in none of the above.
Secondary outcome: Use of therapy at 5 years old
Information about use of medico-educational therapies at the moment of the 5 year old exami-
nation were collected, and were divided into no treatment, one treatment (for example speech
and language therapy), or multiple treatments. These therapies were mainly prescribed by the
professionals in the Unit.
Statistical methods
Data were analyzed with Stata version 13 (Statacorp, Texas, USA). The population characteris-
tics were reported in means (standard deviations) for continuous variables and frequencies (%)
for binary and categorical variables. Differences among subgroups of infants with or without
SGA were assessed using t-tests and chi-square tests, respectively.
The z-scores of the cognitive scores and the behavioral scores were analyzed with univariate
linear regression models first. Risk factors that had a p-value below 0.2 in the univariate analy-
sis were explored with multivariate linear regression models, using a step forward and a step
backward methodology. Results are reported in the table as coefficients with the 95% confi-
dence intervals, additionally beta weights were calculated to evaluate the size of the effect, but
are not reported for all variables as they were weak.
Neurodevelopmental impairment was analyzed with simple univariate logistic regression,
using a step forward and a step backward methodology, retaining for the multivariate analysis
the variables that had a p value< 0.2.
Finally, the analysis of use of therapy implied a multinomial logistic regression, first in a
univariate model, and then in a multivariate model. Again, we only included in the multivariate
model the variables that had a p-value<0.2 in the univariate model. All the results of the logis-
tic regressions are given as coefficients with 95% confidence intervals and p values.
Results
During the six years of the study period, 523 patients born before 32 weeks of gestation were
hospitalized in our tertiary care Neonatology Clinic, with a mortality rate of 12.4% (AGA
11.2% and SGA 14.7%, p = 0.351), as shown in Fig 1.
The rate of follow-up was 342/450 (76%) at 5 years old. There was no statistically significant
difference in most of the neonatal pathologies between lost or followed infants except for multiple
Neurodevelopment of Small for Gestational Age Preterm Infants
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births (who tended to be less followed), and children who had suffered from BPD who were
more often followed. The population had 54/342(15.8%) of SGA infants. The other main neona-
tal characteristics are described in Table 1.
Fig 1. Flow chart of the study population.
doi:10.1371/journal.pone.0125769.g001
Table 1. Population characteristics.
Alln = 342 SGA154 (15.8%) AGA2288 (84.2%) p value*AGA versus SGA
Antenatal characteristics
Antenatal steroids (n, %) 218/333 (65) 37/54 (68) 181/279 (65) 0.606
Outborn (n, %) 61 (17.9) 8 (14.8) 53 (18.5) 0.521
Male gender (n, %) 175 (50.8) 28 (51.8) 146 (50.7) 0.876
Multiple gestation (n, %) 78 (22.3) 10 (18.5) 68 (23.6) 0.413
Gestational age (weeks) (mean, SD, range) 28.4(6.8,24–31.8) 28.5(6.8,24–31.8) 28.6(2,24–31.8) 0.640
Neonatal characteristics
Birthweight (g)(mean, SD, range) 1158(348,380–2280) 784(191,380–1415) 1228(325,650–2280) < 0.001
Asphyxia (Apgar < 6 at 5 min.) (n, %) 94 (28.1) 19 (35.2) 75 (26.8) 0.209
Asphyxie (pH<7.0) (n, %) 17 (5.5) 1 (1.9) 16 (6.3) 0.209
Proven sepsis (n, %) 48 (14.0) 8 (14.8) 40 (13.9) 0.857
Major brain lesions (n, %) 42 (15.8) 9 (22.0) 33 (14.6) 0.252
Proven enterocolitis (n, %) 14 (4.0) 8 (14.8) 6 (2.0) < 0.001
Bronchopulmonary dysplasia (n, %) 102 (30.0) 26 (49.0) 76 (26.6) 0.001
Maternal characteristics
Largo score (mean, SD, range) 6.6(2.5, 2–12) 5.9(5.8, 2–12) 6.8(6.8, 2–12) 0.014
Smoking during pregnancy (n, %) 67 (21.7) 16 (31.4) 51 (19.8) 0.066
*p values were calculated by t-tests for continuous variables and by the chi2 test for categorical or binary outcomes.
1: SGA: small for gestational age, birthweight< percentile 10.
2: AGA: appropriate for gestational age, birthweight> percentile 10
doi:10.1371/journal.pone.0125769.t001
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Primary outcomes
Cognitive outcome analyzed with z-score. Patients were examined at a mean age of 65
months (SD 4.6, range 45–87). Cognitive score, assessed with the K-ABC,WPPSI-III or McCar-
thy tests showed a mean z-score of- 0.4, SD 1.2, with an approximately normal distribution, and
no statistically significant difference between SGA (-0.56) and AGA (-0.38) (p = 0.316). There
were 27/342 (7.9%) of children with a z-score<- 2, corresponding to the definition of mental re-
tardation. Table 2 shows the results of the linear regression analysis of the cognitive z-scores.
There was no statistically significant association between SGA and cognitive outcome. Univariate
regression showed an association of gestational age (coefficient 0.02 per additional day with a p
value< 0.001, and thus 0.14 per additional week of gestation, which would be 2 points of intellec-
tual quotient per week), proven BPD, sepsis, major brain lesions and socio-economic status with
cognitive outcome. In the multivariate model, the neonatal variables associated with cognitive de-
velopment were gestational age, major brain lesions and socio-economic status. The global effect
of this model was still moderate, with r2 at 0.2, and the size of the effects, as measured by beta
weights, was weak to moderate (0.19 for gestational age, 0.26 for major brain lesions). Most of
the variables had a negative effect on the cognitive score, except for additional gestational days.
Behavioral outcome. Behavior was assessed with the SDQ, available for 259 children, of
which was extracted a total problem score and five subscales. SGA was associated with the hy-
peractivity subscale (coefficient 0.81, p< 0.04), but with no other scale, as shown in Table 3.
Univariate analysis showed a significant association between male gender (coefficient 0.71,
p<0.02), BPD (coefficient 0.67, p<0.03), and asphyxia based on a cord blood pH below 7.0 (co-
efficient -1.49, p<0.03) with the hyperactivity subscale. In the multivariate analysis, only male
Table 2. Regression analysis of cognitive outcome.
Univariate Multivariate
Coefﬁcient (95% CI) p value Coefﬁcient (95% CI) p value
Antenatal characteristics
SGA1 -0.18 (-0.54–0.17) 0.316 -0.22(-0.59 0.15) 0.239
Gestational age 0.02 (0.01–0.03) <0.001 0.01 (0.01 0.03) 0.003
Multiple gestation 0.21 (-0.10–0.52) 0.187 -0.03 (-0.35 0.29) 0.851
Male gender -0.05 (-0.31–0.21) 0.716 — —
Neonatal characteristics
Asphyxia (pH) -0.19 (-0.79–0.42) 0.525 — —
Asphyxia (Apgar) -0.34 (-0.63–0.05) 0.022 -0.08 (-0.39 0.22) 0.603
Necrotizing Enterocolitis -0.31(-0.97 0.34) 0.349 — —
Sepsis - 0.5 (-0.88–0.13) 0.008 -0.29 (- 0.68 0.09) 0.140
BPD2 - 0.35 (-0.63–0.07) 0.015 -0.08 (- 0.41 0.24) 0.606
Major brain lesions -1.02 (-1.41–0.64) <0.001 - 0.91(-1.33–0.49) <0.001
Characteristics related to the mother
Socio-economic status (ref: high)
Middle - 0.61 (-0.91–3.17) <0.001 -0.53 (- 0.85–0.22) 0.001
Low - 0.98 (-1.35–0.61) <0.001 - 0.99 (-1.39–0.59) <0.001
Smoking - 0.23 (-0.57 0.10) 0.169 -0.10 (- 0.43 0.22) 0.532
1: SGA: Small for gestational age.
2: BPD: bronchopulmonary dysplasia.
Values are coefﬁcients (95% conﬁdence interval) calculated with linear regression. The variables with p< 0.2, were retained for the multivariate regression,
except for SGA, retained in all the analysis.
doi:10.1371/journal.pone.0125769.t002
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gender and SGA were statistically significant (SGA, coef. 0.77, p = 0.042, male gender (coef.
0.69, p = 0.014). There was a statistically significant association between multiple pregnancy
and the relational score (coef. -0.49, p = 0.033, better relational abilities in multiplets), and gen-
der and the prosocial score (coef. - 0.47, p = 0.021, better prosocial abilities in girls). Univariate
analysis did not show any statistical association between prenatal or postnatal factors and the
total score, nor the emotional or the behavioral subscale.
Neurological outcome. Neurological examination revealed cerebral palsy in 20/345
(5.8%) of the examined children, deafness in 3/345 (0.87%), there were no blind children in
this population. The risk of neurodevelopmental impairment, defined as cerebral palsy, mental
retardation, blindness or deafness, was explored with logistic regression, using the same perina-
tal variables. Being SGA was not associated with neurodevelopmental impairment, as shown in
Table 4. The variables gestational age, asphyxia, and major brain lesions, were significantly as-
sociated with neurodevelopmental impairment in both the univariate and the multivariate
models, whereas low socio-economic status was only in the univariate model. In the multivari-
ate model, the significant predictors of neurodevelopmental impairment were thus tobacco
consumption during pregnancy, gestational age, major brain lesions and birth asphyxia, de-
fined with a cord blood pH below 7.0.
Secondary outcome: Need of therapy
Information about use of therapy at five years old was available for 331/342 (96.8%) fol-
lowed children. Use of therapy was explored with multinomial logistic regression, as this
item was broken down in 2 endpoints, use of one type of therapy (for example, physiothera-
py, speech and language) or use of several therapies (for example physiotherapy and occu-
pational therapy). Most of the children did not need any therapy (236/331, 71.3%), some
needed one therapy at the age of 5 years old (57/331, 17.2%), and 38/331 (11.5%) needed
several therapies.
As shown in Table 5, being SGA was not associated with increased use of using therapy,
both in the univariate and in the multivariate model.
The neonatal variables associated with the use of a single therapy were different from those
of multiple therapies. The multivariate multinomial model was highly significant (p< 0.001),
and showed that gestational age, necrotizing enterocolitis and birth asphyxia were associated
with the use of a single therapy, whereas the need for multiple therapies was solely predicted by
major brain lesions.
Discussion
In this large cohort of very premature infants, our aim was to evaluate the relative impact of
being born SGA on a list of outcomes describing different aspects of child development. SGA
Table 3. Strengths and Difficulties results.
Scores (mean) All SGA AGA p value
Total score 9.38 10.07 9.25 0.346
Emotional symptoms 2.04 2.21 2.00 0.524
Conduct problems 1.92 2.16 1.87 0.280
Hyperactivity-inattention 3.63 4.30 3.5 0.033
Peer problems 1.48 1.43 1.49 0.819
Prosocial behavior 8.26 8.57 8.19 0.173
doi:10.1371/journal.pone.0125769.t003
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was associated with hyperactivity symptoms at the age of 5 years old, but was not associated
with cognitive scores, nor with neurodevelopmental impairment or with the use of therapy.
Behavior was assessed with the Strengths and Difficulties Questionnaire, a validated tool ex-
ploring different aspects of it. None of the neonatal variables was associated with the total diffi-
culty score. Being SGA did have an impact on behavioral issues, with higher scores on the
hyperactivity scale. This result is similar to the results of a recent publication comparing SGA
versus AGA premature infants in a cohort study[13], as well as those of a large Finish study
[27]. Male gender was a risk factor for hyperactive behavior as well, as is described in the gener-
al population[28]. A known risk factor for behavioral issues in term children[29], smoking in
pregnancy, showed no association with the SDQ in this population. This is in accordance with
the results of a recent study reporting an associations of birthweight with inhibitory control
and brain volumes in term born adolescents, but no effect of maternal smoking[30].
Cognitive development in our population was mainly associated with gestational age and
socio-economic status. The impact of social factors has been shown in other studies [19, 31]
especially for premature born infants[32, 33]. There was an association of birth asphyxia in
the univariate model, which disappeared in the multivariate model. We found no association
of SGA with cognitive outcome, contrary to Kok et al[34], or McCarton et al, who published
cohort studies in the nineties with similar definitions (birthweight< 10th percentile)[35].
Neurodevelopmental impairment This third outcome, defined by the presence of cerebral
palsy, mental delay, blindness or deafness was not associated with being SGA in our study con-
trary to the above-mentioned study by Morsing, et al. Gestational age and severe brain lesions
were major determinants of neurodevelopmental impairment, such as is usually reported in
Table 4. Neonatal predictors of neurodevelopmental impairment.
Univariate Multivariate
Coefﬁcient (95% CI) p value Coefﬁcient (95% CI) p value
Antenatal characteristics
SGA1 -0.12 (-1.03 0.79) 0.795 -0.39 (-1.64 0.86) 0.541
Gestational age (days) 0.03 (-0.05 0.01) 0.008 -0.03 (-0.07–0.01) 0.047
Multiple gestation 0.44 (-1.29 0.41) 0.308 — —
Male gender 0.27 (-0.38 0.91) 0.420 — —
Neonatal characteristics
Asphyxia (pH) 1.18 (0.08 2.28) 0.035 1.44 (0.01 2.88) 0.050
Asphyxia (Apgar) 0.29 (-0.39 0.98) 0.402 — —
Necrotizing Enterocolitis 0.71(-0.60 2.03) 0.289 — —
Sepsis 0.55 (-0.25 1.36) 0.177 -0.49 (-1.62 0.63) 0.392
BPD2 0.52 (-0.14 1.19) 0.121 -.09 (-1.07 0.88) 0.845
Major brain lesions 2.80 (2.04 3.56) <0.001 3.07 (2.09 4.06) < 0.001
Characteristics related to the mother
Socio-economic status (ref: high)
Middle 0.38 (-0.47 1.23) 0.384 0.29 (-0.80 1.38) 0.600
Low -0.95 (0.01 1.89) 0.047 1.15 (-0.12 2.43) 0.076
Smoking 0.73 (-0.01 1.46) 0.051 1.12 (0.17 2.07) 0.020
1: SGA: Small for gestational age.
2: BPD: bronchopulmonary dysplasia.
Values are coefﬁcients (95% conﬁdence interval) calculated with logistic regression. The variables with p< 0.2, were retained for the multivariate
regression, except for SGA, retained in all the analysis.
doi:10.1371/journal.pone.0125769.t004
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the literature, as well as asphyxia, which is rarely mentioned in premature infants. A low socio-
economic status was significantly associated with impairment in the univariate model, but not
in the multivariate model. Fetal smoking exposition was associated with impairment solely in
the multivariate model.
Therapy Finally, we chose to assess the need of therapy, that can be present in up to 36% of
a typical term population when only one therapy is needed[36]. We distinguished patients who
needed several therapies, who represent the more impaired children, from those needing only
one therapy. The risk factors were clearly different in these two populations; gestational age,
necrotizing enterocolitis and birth asphyxia increased the risk of need of one therapy, whereas
only major brain lesions were associated with multiple therapies. Although the usefulness of
many forms of therapy has not been clearly demonstrated yet, therapy is generally considered
useful by clinicians. It can thus be a good indirect indicator of the special needs of a child, as
well as of the additional burden for families and society.
Among other important risk factors and potential confounders, tobacco deserves special
attention. A relationship between smoking and socio-economic status is often reported, and
some authors postulate that the impact of socio-economic status on cognitive outcome could
be partially mediated by tobacco[37]. In our study this relationship was not verified, and we
found no association between tobacco and cognitive or behavioral outcome, but there is never-
theless a significant impact on neurodecvelopmental impairment. Unfortunately, the
Table 5. Neonatal predictors of use of therapy.
SINGLE THERAPY MULTIPLE THERAPIES


















SGA1 0.49 (-0.24 1.23) 0.187 0.26 (-0.69 1.22) 0.586 0.14 (-0.80 1.08) 0.768 -0.12 (-1.39 1.15) 0.852
Gestational age (days) -0.03 (-0.05–0.01) 0.002 -0.03 (-0.06–0.01) 0.026 -0.01(-0.04 0.01) 0.159 -0.02 (-0.05 0.01) 0.181
Multiple gestation 0.19 (-0.48 0.87) 0.580 0.41 (-0.35 1.18) 0.288
Male gender 0.38 (-0.19 0.97) 0.195 0.28 (-0.42 0.98) 0.435 0.38 (-0.30 1.07) 0.277 0.72 (-0.15 1.59) 0.107
Neonatal characteristics
Asphyxia (pH) 1.19 (0.08 2.29) 0.035 1.47 (-0.08 2.94) 0.049 0.86(-0.51 2.24) 0.220 1.53 (-0.46 3.53) 0.132
Asphyxia (Apgar) 0.46 (-0.16 1.08) 0.148 0.19 (-0.64 1.04) 0.647 -0.15 (-0.95 0.65) 0.712 -1.15 (-2.45 0.14) 0.080
Necrotizing Enterocolitis 1.86 (0.68 3.05) 0.002 1.71 (0.20 3.21) 0.026 0.22 (-1.95 2.39) 0.841 0.17 (-2.61 2.27) 0.891
Sepsis 0.11 (-0.72 0.95) 0.790 0.43 (-0.46 1.34) 0.342
BPD2 0.90 (0.30 1.50) 0.003 0.31 (-0.48 1.10) 0.445 0.65 (-0.06 1.36) 0.073 0.32 (-0.67 1.31) 0.527
Major brain lesions 0.98 (0.18 1.79) 0.016 0.26 (-0.81 1.33) 0.635 1.73 (0.92 2.55) <0.001 2.06 (1.03 3.09) < 0.001
Characteristics related to the mother
Socio-economic status
(ref: high)
Middle -0.01 (-0.66 0.64) 0.981 0.41 (-0.42 1.25) 0.334 -0.70 (-1.58 0.18) 0.122 -0.99 (-2.04 0.05) 0.062
Low -0.62 (-1.62 0.38) 0.228 -0.84 (-2.31 0.62) 0.258 0.79 (-0.06 1.65) 0.070 0.79 (-0.27 1.87) 0.145
Smoking 0.04 (-0.69 0.79) 0.901 0.11 (-0.74 0.97) 0.791 0.54 (-0.24 1.32) 0.176 0.88 (-0.07 1.84) 0.072
Values are coefﬁcients (95% conﬁdence interval) calculated with multinomial logistic regression. The variables with p< 0.2 for single or multiple therapies
were retained for multivariate regression.
1: SGA: small for gestational age, birthweight < percentile 10.
2: BPD: bronchopulmonary dysplasia.
doi:10.1371/journal.pone.0125769.t005
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information about smoking did not include quantitative data, such as number of cigarettes per
day, which could have led to different results. However, tobacco during pregnancy is certainly
the main risk factor that could be actively prevented or limited in this population.
Limitations
Although the data were prospectively collected in an ad hoc database, the retrospective nature of
the analysis involves some risk of bias. The follow-up rate of 76% is another potential source of
bias; the dropouts showed that they tended to come more frommultiple births, and were slightly
less ill in the neonatal period (less BPD). Another limitation is the use of different cognitive
scores at the age of five years. Children tested with tests other than the K-ABC had more develop-
mental issues, and there was a significant difference between the mean scores obtained with the
K-ABC or the other tests. We therefore chose not to exclude these more impaired children from
our analysis, and combined all the results with z-scores, as has been previously published[22].
It is also important to note that, in our study, the definition of SGA was a birth
weight< 10th percentile based on Voigt, et al curves[16], which is one of the commonest used
in the literature, but is not the only one [38]. The use of the 10th percentile alone does not allow
to identify infants especially at risk for adverse neurodevelopmental outcome; however, it is
possible that definitions or classifications that better discriminate SGA form IUGR would be
more predictive. For example, the use of customized growth curves for neonates, which take
into consideration mother’s weight, height, and parity, could be more discriminative, as could
be the precise documentation of intrauterine fetal growth restriction (IUGR), and of Doppler
information [39, 40]. The prospective collection of these variables should contribute to better
understand the risk factors of premature infants.
In conclusion, SGA (defined as birthweight< 10th percentile) in premature infants seems to
have a slight impact on neurodevelopment at the age of 5 years old, with more hyperactivity
symptoms. No association was found with cognitive development, severe neurodevelopmental
impairment or the need of therapy. The impact of IUGR identified with more specific ap-
proaches remains to be elucidated. The most potent predictors of neurodevelopment were ges-
tational age, major brain lesions, socioeconomic status, birth asphyxia, and tobacco exposition
during pregnancy. A future target of research, aimed at evaluating what is changeable, could be
educational intervention in low-income families of premature children, especially for SGA chil-
dren, and of course smoking counseling for mothers-to-be.
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